Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Amisulpride 50mg Tablet – PA0577/182/001
- Amisulpride 200mg Tablet – PA0577/182/002
- Amoxil 500mg Powder for Solution for Injection or Infusion – PA1077/033/004
- Azithromycin Teva 250mg Film Coated Tablet – PA0749/039/002
- Cordarone X Intravenous 150mg/3ml Concentrate for Solution for Infusion or Slow Injection – PA0540/142/003
- Gerozac 20mg Capsule – PA0577/200/001
- Gerozac 60mg Capsule – PA0577/071/001
- Olmesartan Medoxomil Clonmel 10mg Film Coated Tablet – PA0126/273/001
- Pabrinex Intraveneous High Potency Concentrate for Solution for Infusion – PA2288/001/001
- Ultiva 2mg Powder for Concentrate for Solution for Infusion – PA1691/032/002
- Valsartan Mylan 320mg Tablet – PA0577/134/004
- Zithromax 250mg Capsule (6 pack presentation only) – PA0822/191/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Arcoxia 120mg Film Coated Tablet – PA1997/001/004
- Cozaar 50mg Film Coated Tablet – PA1286/004/002
- Efexor XL 37.5mg Prolonged Release Capsule – PA0822/072/001
- Epanutin 30mg/5ml Oral Suspension – PA0822/011/007
- Estradot 50mcg Transdermal Patch – PA0896/010/002
- Glypressin 1mg Powder and Solvent for Solution for Injection – PA1009/004/001
- Lecalpin 20mg Tablet – PA2315/186/002
- Menopur 600IU Powder and Solvent for Solution for Injection – PA1009/015/002
- Mivacron 2mg/ml Solution for Injection – PA1691/033/001
- Ondansetron 4mg Tablet – PA0749/009/001
- Septrin 80mg/400mg Tablet – PA1691/010/001
- Valsartan Hydrochlorothiazide Teva 80mg/12.5mg Tablet - PA0749/047/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.